Innate responses induced by whole inactivated virus or subunit influenza vaccines in cultured dendritic cells correlate with immune responses in vivo

PLoS ONE

Volumn 10, Issue 5, 2015, Pages

  Stoel, Maaike ^a   Pool, Judith ^a   De Vries Idema, Jacqueline ^a   Zaaraoui Boutahar, Fatiha ^b   Bijl, Maarten ^b   Andeweg, Arno C ^b   Wilschut, Jan ^a   Huckriede, Anke ^a  

^a UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^b ERASMUS UNIVERSITY ROTTERDAM   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

INFLUENZA VACCINE; NEUTRALIZING ANTIBODY; SUBUNIT INFLUENZA VACCINE; UNCLASSIFIED DRUG; VIRUS VACCINE; WHOLE INACTIVATED INFLUENZA VIRUS VACCINE; CYTOKINE; INACTIVATED VACCINE; SUBUNIT VACCINE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANTIBODY RESPONSE; ANTIBODY TITER; ARTICLE; BONE MARROW DERIVED DENDRITIC CELL; CELL CULTURE; CELL STIMULATION; CELLULAR IMMUNITY; CONTROLLED STUDY; CORRELATIONAL STUDY; CYTOKINE RELEASE; FEMALE; GENE EXPRESSION PROFILING; GENE ONTOLOGY; IMMUNOGENICITY; IN VITRO STUDY; IN VIVO STUDY; INFLUENZA; INFLUENZA VACCINATION; INNATE IMMUNITY; MOUSE; NONHUMAN; TH1 CELL; ANIMAL; BAGG ALBINO MOUSE; BIOSYNTHESIS; BONE MARROW CELL; CYTOLOGY; DENDRITIC CELL; GENE EXPRESSION REGULATION; GENETICS; IMMUNOLOGY; ORTHOMYXOVIRUS INFECTION; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; UPREGULATION; VIROLOGY;

ANIMALIA; MURINAE; MUS;

ANIMALS; BONE MARROW CELLS; CELLS, CULTURED; CYTOKINES; DENDRITIC CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; GENE ONTOLOGY; IMMUNITY, INNATE; INFLUENZA VACCINES; MICE, INBRED BALB C; ORTHOMYXOVIRIDAE INFECTIONS; PHENOTYPE; PRINCIPAL COMPONENT ANALYSIS; UP-REGULATION; VACCINES, INACTIVATED; VACCINES, SUBUNIT;

EID: 84928787976     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0125228     Document Type: Article

References (37)

1. Nabel GJ. Designing tomorrow's vaccines. N Engl J Med. 2013; 368: 551-560. doi: 10.1056/NEJMra1204186 PMID: 23388006
2. Plotkin SA, Plotkin SL. The development of vaccines: How the past led to the future. Nat Rev Microbiol. 2011; 9: 889-893. doi: 10.1038/nrmicro2668 PMID: 21963800
3. Rappuoli R, Mandl CW, Black S, De Gregorio E. Vaccines for the twenty-first century society. Nat Rev Immunol. 2011; 11: 865-872. doi: 10.1038/nri3085 PMID: 22051890
4. Kaufmann SH. Fact and fiction in tuberculosis vaccine research: 10 years later. Lancet Infect Dis. 2011; 11: 633-640. doi: 10.1016/S1473-3099(11)70146-3 PMID: 21798463
5. Pulendran B. Modulating vaccine responses with dendritic cells and toll-like receptors. Immunol Rev. 2004; 199: 227-250. PMID: 15233738
6. Steinman RM. Decisions about dendritic cells: Past, present, and future. Annu Rev Immunol. 2012; 30: 1-22. doi: 10.1146/annurev-immunol-100311-102839 PMID: 22136168
7. Wilschut JC, McElhaney JE, Palache AM. Vaccination: Cornerstone of influenza control. In: Wilschut JC, McElhaney JE, Palache AM, editors. Influenza.: Elsevier; 2006. p. 150-183.
8. Geeraedts F, Bungener L, Pool J, ter Veer W, Wilschut J, Huckriede A. Whole inactivated virus influenza vaccine is superior to subunit vaccine in inducing immune responses and secretion of proinflammatory cytokines by DCs. Influenza and Other Respiratory Viruses. 2008; 2: 41-51. doi: 10.1111/j.1750-2659.2008.00038.x PMID: 19453471
9. Stephenson I, Nicholson KG, Gluck R, Mischler R, Newman RW, Palache AM, et al. Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: Phase I randomised trial. Lancet. 2003; 362: 1959-1966. PMID: 14683655
10. Kark JD, Lebiush M, Rannon L, Witztum E, Nili E, Kedem R. The antigenicity of whole virus versus subunit trivalent influenza vaccines-a field trial in the israel defence forces, 1978. Med Microbiol Immunol. 1981; 170: 55-62. PMID: 7029236
11. Balkovic ES, Florack JA, Six HR. Immunoglobulin G subclass antibody responses of mice to influenza virus antigens given in different forms. Antiviral Res. 1987; 8: 151-160. PMID: 3426185
12. Bernstein DI, Zahradnik JM, DeAngelis CJ, Cherry JD. Clinical reactions and serologic responses after vaccination with whole-virus or split-virus influenza vaccines in children aged 6 to 36 months. Pediatrics. 1982; 69: 404-408. PMID: 7070886
13. Budimir N, Huckriede A, Meijerhof T, Boon L, Gostick E, Price DA, et al. Induction of heterosubtypic cross-protection against influenza by a whole inactivated virus vaccine: The role of viral membrane fusion activity. PLoS One. 2012; 7: e30898. doi: 10.1371/journal.pone.0030898 PMID: 22303469
14. Geeraedts F, Goutagny N, Hornung V, Severa M, de Haan A, Pool J, et al. Superior immunogenicity of inactivated whole virus H5N1 influenza vaccine is primarily controlled by toll-like receptor signalling. PLoS Pathog. 2008; 4: e1000138. doi: 10.1371/journal.ppat.1000138 PMID: 18769719
15. Peterson GL. A simplification of the protein assay method of lowry et al. which is more generally applicable. Anal Biochem. 1977; 83: 346-356. PMID: 603028
16. Lutz MB, Kukutsch N, Ogilvie AL, Rossner S, Koch F, Romani N, et al. An advanced culture method for generating large quantities of highly pure dendritic cells from mouse bone marrow. J Immunol Methods. 1999; 223: 77-92. PMID: 10037236
17. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Statistical Applications in Genetics and Molecular Biology 3 (1) 2004, Article 3.
18. Huang da W, Sherman BT, Zheng X, Yang J, Imamichi T, Stephens R, et al. Extracting biological meaning from large gene lists with DAVID. Curr Protoc Bioinformatics. 2009. Chapter 13: Unit 13.11.
19. Huang da W, Sherman BT, Lempicki RA. Bioinformatics enrichment tools: Paths toward the comprehensive functional analysis of large gene lists. Nucleic Acids Res. 2009; 37: 1-13. doi: 10.1093/nar/gkn923 PMID: 19033363
20. Huang da W, Sherman BT, Lempicki RA. Systematic and integrative analysis of large gene lists using DAVID bioinformatics resources. Nat Protoc. 2009; 4: 44-57. doi: 10.1038/nprot.2008.211 PMID: 19131956
21. Halbroth BR, Heil A, Distler E, Dass M, Wagner EM, Plachter B, et al. Superior in vitro stimulation of human CD8+ T-cells by whole virus versus split virus influenza vaccines. PLoS One. 2014; 9: e103392. doi: 10.1371/journal.pone.0103392 PMID: 25072749
22. Diebold SS, Kaisho T, Hemmi H, Akira S, Reis e Sousa C. (2004) Innate antiviral responses by means of TLR7-mediated recognition of single-stranded RNA. Science 303: 1529-1531. PMID: 14976261
23. Budimir N, de Haan A, Meijerhof T, Waijer S, Boon L, Gostick E, et al. Critical role of TLR7 signaling in the priming of cross-protective cytotoxic T lymphocyte responses by a whole inactivated influenza virus vaccine. PLoS One. 2013; 8(5): e63163. doi: 10.1371/journal.pone.0063163 PMID: 23658804
24. Hovden AO, Cox RJ, Haaheim LR. Whole influenza virus vaccine is more immunogenic than split influenza virus vaccine and induces primarily an IgG2a response in BALB/c mice. Scand J Immunol. 2005; 62: 36-44. PMID: 16092921
25. Hagenaars N, Mastrobattista E, Glansbeek H, Heldens J, van den Bosch H, Schijns V, et al. Head-tohead comparison of four nonadjuvanted inactivated cell culture-derived influenza vaccines: Effect of composition, spatial organization and immunization route on the immunogenicity in a murine challenge model. Vaccine. 2008; 26: 6555-6563. doi: 10.1016/j.vaccine.2008.09.057 PMID: 18848856
26. Geeraedts F, Huckriede A. Influenza vaccines: What do we want and how can we get it? Adv Exp Med Biol. 2011; 780: 161-174. doi: 10.1007/978-1-4419-5632-3-13 PMID: 21842372
27. Fazekas G, Rosenwirth B, Dukor P, Gergely J, Rajnavolgyi E. IgG isotype distribution of local and systemic immune responses induced by influenza virus infection. Eur J Immunol. 1994; 24: 3063-3067. PMID: 7805734
28. Coutelier JP, van der Logt JT, Heessen FW, Warnier G, Van Snick J. IgG2a restriction of murine antibodies elicited by viral infections. J Exp Med. 1987; 165: 64-69. PMID: 3794607
29. Proietti E, Bracci L, Puzelli S, Di Pucchio T, Sestili P, De Vincenzi E, et al. Type I IFN as a natural adjuvant for a protective immune response: Lessons from the influenza vaccine model. J Immunol. 2002; 169: 375-383. PMID: 12077267
30. Le Bon A, Schiavoni G, D'Agostino G, Gresser I, Belardelli F, Tough DF. Type i interferons potently enhance humoral immunity and can promote isotype switching by stimulating dendritic cells in vivo. Immunity. 2001; 14: 461-470. PMID: 11336691
31. Coro ES, Chang WL, Baumgarth N. Type I IFN receptor signals directly stimulate local B cells early following influenza virus infection. J Immunol. 2006; 176: 4343-4351. PMID: 16547272
32. Chang WL, Coro ES, Rau FC, Xiao Y, Erle DJ, Baumgarth N. Influenza virus infection causes global respiratory tract B cell response modulation via innate immune signals. J Immunol. 2007; 178: 1457-1467. PMID: 17237394
33. Heer AK, Shamshiev A, Donda A, Uematsu S, Akira S, Kopf M, et al. TLR signaling fine-tunes anti-influenza B cell responses without regulating effector T cell responses. J Immunol. 2007; 178: 2182-2191. PMID: 17277123
34. Seubert A, Monaci E, Pizza M, O'Hagan DT, Wack A. The adjuvants aluminum hydroxide and MF59 induce monocyte and granulocyte chemoattractants and enhance monocyte differentiation toward dendritic cells. J Immunol. 2008; 180: 5402-5412. PMID: 18390722
35. Li S, Rouphael N, Duraisingham S, Romero-Steiner S, Presnell S, Davis C, et al. Molecular signatures of antibody responses derived from a systems biology study of five human vaccines. Nat Immunol. 2014; 15: 195-204. doi: 10.1038/ni.2789 PMID: 24336226
36. Nakaya HI, Wrammert J, Lee EK, Racioppi L, Marie-Kunze S, Haining WN, et al. Systems biology of vaccination for seasonal influenza in humans. Nat Immunol. 2011; 12: 786-795. doi: 10.1038/ni.2067 PMID: 21743478
37. Querec TD, Akondy RS, Lee EK, Cao W, Nakaya HI, Teuwen D, et al. Systems biology approach predicts immunogenicity of the yellow fever vaccine in humans. Nat Immunol. 2009; 10: 116-125. doi: 10.1038/ni.1688 PMID: 19029902